Current and historical daily PE Ratio for Shan Dong Kexing Bioproducts Co Ltd (
SHSE:688136
) from 2020 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Shan Dong Kexing Bioproducts stock (SHSE:688136) PE ratio as of Jun 09 2024 is 0.
More Details
Shan Dong Kexing Bioproducts Co Ltd (SHSE:688136) PE Ratio (TTM) Chart
Shan Dong Kexing Bioproducts Co Ltd (SHSE:688136) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 845
- 1
- 2
- 3
- 4
- 5
- 6
- 10
| Shan Dong Kexing Bioproducts PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | At Loss | 2024-04-01 | At Loss |
| 2024-06-07 | At Loss | 2024-03-29 | At Loss |
| 2024-06-06 | At Loss | 2024-03-28 | At Loss |
| 2024-06-05 | At Loss | 2024-03-27 | At Loss |
| 2024-06-04 | At Loss | 2024-03-26 | At Loss |
| 2024-06-03 | At Loss | 2024-03-25 | At Loss |
| 2024-05-31 | At Loss | 2024-03-22 | At Loss |
| 2024-05-30 | At Loss | 2024-03-21 | At Loss |
| 2024-05-29 | At Loss | 2024-03-20 | At Loss |
| 2024-05-28 | At Loss | 2024-03-19 | At Loss |
| 2024-05-27 | At Loss | 2024-03-18 | At Loss |
| 2024-05-24 | At Loss | 2024-03-15 | At Loss |
| 2024-05-23 | At Loss | 2024-03-14 | At Loss |
| 2024-05-22 | At Loss | 2024-03-13 | At Loss |
| 2024-05-21 | At Loss | 2024-03-12 | At Loss |
| 2024-05-20 | At Loss | 2024-03-11 | At Loss |
| 2024-05-17 | At Loss | 2024-03-08 | At Loss |
| 2024-05-16 | At Loss | 2024-03-07 | At Loss |
| 2024-05-15 | At Loss | 2024-03-06 | At Loss |
| 2024-05-14 | At Loss | 2024-03-05 | At Loss |
| 2024-05-13 | At Loss | 2024-03-04 | At Loss |
| 2024-05-10 | At Loss | 2024-03-01 | At Loss |
| 2024-05-09 | At Loss | 2024-02-29 | At Loss |
| 2024-05-08 | At Loss | 2024-02-28 | At Loss |
| 2024-05-07 | At Loss | 2024-02-27 | At Loss |
| 2024-05-06 | At Loss | 2024-02-26 | At Loss |
| 2024-04-30 | At Loss | 2024-02-23 | At Loss |
| 2024-04-29 | At Loss | 2024-02-22 | At Loss |
| 2024-04-26 | At Loss | 2024-02-21 | At Loss |
| 2024-04-25 | At Loss | 2024-02-20 | At Loss |
| 2024-04-24 | At Loss | 2024-02-19 | At Loss |
| 2024-04-23 | At Loss | 2024-02-08 | At Loss |
| 2024-04-22 | At Loss | 2024-02-07 | At Loss |
| 2024-04-19 | At Loss | 2024-02-06 | At Loss |
| 2024-04-18 | At Loss | 2024-02-05 | At Loss |
| 2024-04-17 | At Loss | 2024-02-02 | At Loss |
| 2024-04-16 | At Loss | 2024-02-01 | At Loss |
| 2024-04-15 | At Loss | 2024-01-31 | At Loss |
| 2024-04-12 | At Loss | 2024-01-30 | At Loss |
| 2024-04-11 | At Loss | 2024-01-29 | At Loss |
| 2024-04-10 | At Loss | 2024-01-26 | At Loss |
| 2024-04-09 | At Loss | 2024-01-25 | At Loss |
| 2024-04-08 | At Loss | 2024-01-24 | At Loss |
| 2024-04-03 | At Loss | 2024-01-23 | At Loss |
| 2024-04-02 | At Loss | 2024-01-22 | At Loss |
Shan Dong Kexing Bioproducts Co Ltd (SHSE:688136) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Shan Dong Kexing Bioproducts Co Ltd
Share Class Description:
SHSE:688136: Class ACompare
Compare
Traded in other countries / regions
688136.China IPO Date
2020-12-14Description
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers